microRNA1281在不同肿瘤中的研究进展
Research Progress of microRNA1281 in Different Tumors
DOI: 10.12677/ACM.2023.1371603, PDF,   
作者: 李冰冰:青海大学研究生院,青海 西宁
关键词: microRNA1281早期诊断标志物靶向治疗microRNA1281 Early Diagnostic Markers Targeted Therapy
摘要: MiRNAs是一种短小(约22个核苷酸)的非编码RNA (NcRNAs),通过与特定的mRNA靶标结合并促进其降解和/或翻译抑制来调节基因的表达。许多研究已经证明microRNAs在癌症生物学中的重要性,它通过控制其靶标mRNAs的表达来促进肿瘤的生长、侵袭、血管生成和免疫逃避。大量研究表明microRNA1281在胃癌、乳腺癌、结直肠肿瘤的血浆、细胞及组织中差异表达,并且在各种肿瘤细胞增殖、侵袭、转移及细胞凋亡中发挥重要的作用。肿瘤细胞可以释放通过结合到微泡中而稳定存在的microRNAs,这些微RNA在多次冻融循环和长期暴露于室温后在循环中仍表现出稳定性。MicroRNAs在其他体液中也表现出稳定性,例如血液、尿液和唾液等。因此MicroRNAs,可以在细胞、组织及生物液中检测到癌症相关的microRNA生物标记物,从而实现更少的侵入性检测。本文旨在对microRNA1281在不同肿瘤中的表达差异及作用机制进行总结,以期为肿瘤患者的诊断、预后、监测和治疗提供新方向。
Abstract: MiRNAs are short (about 22 nucleotides) non-coding Rnas (NcRNAs) that regulate gene expression by binding to specific mRNA targets and promoting their degradation and/or translation inhibition. Many studies have demonstrated the importance of microRNAs in cancer biology, which promote tumor growth, invasion, angiogenesis, and immune evasion by controlling the expression of their target mRNAs. Numerous studies have shown that microRNA1281 is differentially expressed in the plasma, cells and tissues of gastric cancer, breast cancer and colorectal cancer, and plays an im-portant role in the proliferation, invasion, metastasis and apoptosis of various tumor cells. Tumor cells can release microRNAs that are stabilized by binding to microvesicles, and these microRNAs remain stable in the cycle after multiple freeze-thaw cycles and long-term exposure to room tem-perature. MicroRNAs also show stability in other body fluids, such as blood, urine and saliva. There-fore, MicroRNAs can detect cancer-related microRNA biomarkers in cells, tissues and biological flu-ids, thus achieving less invasive detection. This paper aims to summarize the expression differences of microRNA1281 in different tumors and the mechanism of action, in order to provide a new direc-tion for the diagnosis, prognosis, monitoring and treatment of tumor patients.
文章引用:李冰冰. microRNA1281在不同肿瘤中的研究进展[J]. 临床医学进展, 2023, 13(7): 11468-11474. https://doi.org/10.12677/ACM.2023.1371603

参考文献

[1] Bartel, D.P. (2004) MicroRNAs: Genomics, Biogenesis, Mechanism, and Function. Cell, 116, 281-297. [Google Scholar] [CrossRef
[2] Lee, R.C., Feinbaum, R.L. and Ambros, V. (1993) The C. elegans Heterochronic Gene lin-4 Encodes Small RNAs with Antisense Complementarity to lin-14. Cell, 75, 843-854. [Google Scholar] [CrossRef
[3] Reinhart, B.J., Slack, F.J., Basson, M., et al. (2000) The 21-Nucleotide let-7 RNA Regulates Developmental Timing in Caenorhabditis elegans. Nature, 403, 901-906. [Google Scholar] [CrossRef] [PubMed]
[4] Goodall, G.J. and Wickramasinghe, V.O. (2021) RNA in Cancer. Nature Reviews Cancer, 21, 22-36. [Google Scholar] [CrossRef] [PubMed]
[5] Pritchard, C.C., Cheng, H.H. and Tewari, M. (2012) MicroRNA Profiling: Approaches and Considerations. Nature Reviews Genetics, 13, 358-369. [Google Scholar] [CrossRef] [PubMed]
[6] Lan, H., Lu, H., Wang, X., et al. (2015) MicroRNAs as Potential Biomarkers in Cancer: Opportunities and Challenges. BioMed Research International, 2015, Article ID: 125094. [Google Scholar] [CrossRef] [PubMed]
[7] Li, Y., Li, L., Qian, Z., et al. (2018) Phosphatidylinositol 3-Kinase-DNA Methyltransferase 1-miR-1281-Histone Deacetylase 4 Regulatory Axis Mediates Platelet-Derived Growth Fac-tor-Induced Proliferation and Migration of Pulmonary Artery Smooth Muscle Cells. Journal of the American Heart As-sociation, 7, e007572. [Google Scholar] [CrossRef
[8] Pignot, G., et al. (2013) microRNA Expression Profile in a Large Series of Bladder Tumors: Identification of a 3- miRNA Signature Associated with Aggressiveness of Muscle-Invasive Bladder Cancer. International Journal of Cancer, 132, 2479-2491. [Google Scholar] [CrossRef] [PubMed]
[9] Farabaugh, S.M., Chan, B.T., Cui, X., et al. (2016) Lack of Interaction be-tween ErbB2 and Insulin Receptor Substrate Signaling in Breast Cancer. Cell Communication and Signaling: CCS, 14, Article No. 25. [Google Scholar] [CrossRef] [PubMed]
[10] Gao, S.-B., Li, K.-L., Qiu, H., et al. (2017) Enhancing Chemo-therapy Sensitivity by Targeting PcG via the ATM/p53 Pathway. American Journal of Cancer Research, 7, 1874-1883.
[11] Gruber, W., Scheidt, T., Aberger, F., et al. (2017) Understanding Cell Signaling in Cancer Stem Cells for Targeted Therapy—Can Phosphoproteomics Help to Reveal the Secrets? Cell Communication and Signaling: CCS, 15, Article No. 12. [Google Scholar] [CrossRef] [PubMed]
[12] Järvelin, A.I., Noerenberg, M., Davis, I., et al. (2016) The New (Dis)order in RNA Regulation. Cell Communication and Signaling: CCS, 14, Article No. 9. [Google Scholar] [CrossRef] [PubMed]
[13] Smyth, E.C., Nilsson, M., Grabsch, H.I., et al. (2020) Gastric Cancer. The Lancet, 396, 635-648. [Google Scholar] [CrossRef
[14] Liu, G., Jiang, Z., Qiao, M., et al. (2019) Lnc-GIHCG Pro-motes Cell Proliferation and Migration in Gastric Cancer through miR-1281 Adsorption. Molecular Genetics & Genomic Medicine, 7, e711. [Google Scholar] [CrossRef] [PubMed]
[15] Kaul, A., Schuster, E. and Jennings, B.H. (2014) The Groucho Co-Repressor Is Primarily Recruited to Local Target Sites in Active Chromatin to Attenuate Transcription. PLoS Genetics, 10, e1004595. [Google Scholar] [CrossRef] [PubMed]
[16] Yao, X., Ireland, S.K., Pham, T., et al. (2014) TLE1 Promotes EMT in A549 Lung Cancer Cells through Suppression of E-Cadherin. Biochemical and Biophysical Research Commu-nications, 455, 277-284. [Google Scholar] [CrossRef] [PubMed]
[17] Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Sta-tistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[18] Harbeck, N., Penault-Llorca, F., Cortes, J., et al. (2019) Breast Cancer. Nature Reviews. Disease Primers, 5, Article No. 66. [Google Scholar] [CrossRef] [PubMed]
[19] Medeiros, B. and Allan, A.L. (2019) Molecular Mechanisms of Breast Cancer Metastasis to the Lung: Clinical and Experimental Per-spectives. International Journal of Molecular Sciences, 20, E2272. [Google Scholar] [CrossRef] [PubMed]
[20] Fan, L.-Y., Shi, K.-Y., Xu, D., et al. (2019) LncRNA GIHCG Regu-lates microRNA-1281 and Promotes Malignant Progression of Breast Cancer. European Review for Medical and Phar-macological Sciences, 23, 10842-10850.
[21] Bao, P.P., et al. (2019) Incidence and Mortality of Sarcomas in Shanghai, China, during 2002-2014. Frontiers in Oncology, 9, Article No. 662. [Google Scholar] [CrossRef] [PubMed]
[22] Lancia, C., Anninga, J.K., Sydes, M.R., et al. (2019) A Novel Method to Address the Association between Received Dose Intensity and Survival Outcome: Benefits of Approaching Treatment Intensification at a More Individualised Level in a Trial of the European Osteosarcoma Intergroup. Cancer Chemotherapy and Pharmacology, 83, 951-962. [Google Scholar] [CrossRef] [PubMed]
[23] Gill, J. and Gorlick, R. (2021) Advancing Therapy for Osteo-sarcoma. Nature Reviews Clinical Oncology, 18, 609-624. [Google Scholar] [CrossRef] [PubMed]
[24] Jiang, J., Ma, B., Li, X., et al. (2018) MiR-1281, a p53-Responsive microRNA, Impairs the Survival of Human Osteosarcoma Cells upon ER Stress via Targeting USP39. American Journal of Cancer Research, 8, 1764-1774.
[25] Ostrom, Q.T., Gittleman, H., Truitt, G., et al. (2018) CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015. Neuro-Oncology, 20, iv1-iv86. [Google Scholar] [CrossRef] [PubMed]
[26] Tan, A.C., Ashley, D.M., López, G.Y., et al. (2020) Management of Glioblastoma: State of the Art and Future Directions. CA: A Cancer Journal for Clinicians, 70, 299-312. [Google Scholar] [CrossRef] [PubMed]
[27] Hu, G., Liu, N., Wang, H., et al. (2019) LncRNA LINC01857 Promotes Growth, Migration, and Invasion of Glioma by Modulating miR-1281/TRIM65 Axis. Journal of Cellular Physiology, 234, 22009-22016. [Google Scholar] [CrossRef] [PubMed]
[28] Ferlay, J., Colombet, M., Soerjomataram, I., et al. (2019) Estimating the Global Cancer Incidence and Mortality in 2018: GLOBOCAN Sources and Methods. International Journal of Cancer, 144, 1941-1953. [Google Scholar] [CrossRef] [PubMed]
[29] Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[30] Johnson, D.E., Burtness, B., Leemans, C.R., et al. (2020) Head and Neck Squamous Cell Carcinoma. Nature Reviews Disease Primers, 6, Article No. 92. [Google Scholar] [CrossRef] [PubMed]
[31] Hufbauer, M., Maltseva, M., Meinrath, J., et al. (2018) HPV16 Increases the Number of Migratory Cancer Stem Cells and Modulates Their miRNA Expression Profile in Oropharynge-al Cancer. International Journal of Cancer, 143, 1426- 1439. [Google Scholar] [CrossRef] [PubMed]